6th Mar 2017 07:00
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | ARIX BIOSCIENCE PLC | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | X | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to thenotification obligation: iii | Takeda Ventures, Inc. | ||||
4. Full name of shareholder(s) (if different from 3.):iv | |||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 17/02/2017 | ||||
6. Date on which issuer notified: | 02 March 2017 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | 5% | ||||
8. Notified details: | |||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | %of voting rightsx | |||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||||||||
Ordinary Shares GB00BD045074 | 0.00 | 0.00 | 4,830,917 | 4,830,917 | 5.4% | ||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||||||||
N/A | |||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| ||||||||||||
N/A | Nominal | Delta | |||||||||||||||
| |||||||||||||||||
Total (A+B+C) | |||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||
4,830,917 | 5.4% | ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | none
| |
11. Number of voting rights proxy holder will cease to hold: | ||
12. Date on which proxy holder will cease to hold voting rights: | ||
13. Additional information: | ||
14. Contact name: |
Michael Martin, Ph.D.
| |
15. Contact telephone number: | +1 650 328 2900 | |
Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in sharesxxii |
A: Identity of the persons or legal entity subject to the notification obligation | |
Full name (including legal form of legal entities) | Takeda Ventures, Inc. |
Contact address (registered office for legal entities) | 435 Tasso Street, Suite 300 Palo Alto, CA 94301 USA |
Phone number & email | Phone: +1 650 328 2900 E-mail: [email protected] |
Other useful information (at least legal representative for legal persons) |
B: Identity of the notifier, if applicable | |
Full name | Michael Martin, Ph.D. |
Contact address | 435 Tasso Street, Suite 300 Palo Alto, CA 94301 USA |
Phone number & email | Phone: +1 650 328 2900 |
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) | President |
C: Additional information |
For notes on how to complete form TR-1 please see the FCA website.
Related Shares:
ARIX.L